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Two males ages 16 and 23 years presented with new testicular pain while taking minocycline. Both
patients experienced resolution of their symptoms only after minocycline discontinuation. Testicular
pain with minocycline use has been previously described, however only in the setting of systemic
autoimmune reactions (which were absent here). These cases represent probable rare adverse reactions
to minocycline. For patients taking minocycline who experience otherwise unexplained testicular pain, a
trial discontinuation of this medication should be considered.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Minocycline is a tetracycline antibiotic commonly used to treat
inﬂammatory skin conditions such as acne vulgaris.1 It has a well-
documented side effect proﬁle that includes several rare but
serious immunologic reactions such as drug-induced lupus-like
syndromes, autoimmune hepatitis, and vasculitis syndromes.2e6
Instances of testicular or scrotal pain associated with minocy-
cline use have been described, however only in the setting of
systemic minocycline-associated vasculitides.7e10 Anecdotally,
associations have been made between minocycline use and
testicular pain as a lone symptom, however this has not been
formally reported. Here we investigate this claim and present
cases of minocycline-associated testicular pain in the absence of
systemic symptoms.Materials and methods
Patients were identiﬁed from the personal experience of
attending urologists at our institution. The patients’ medical
records were reviewed and the information compiled for this
study.ncial interests. There are no
dgments for this study.
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Case reports
Case 1
A 16 year-old Caucasian boy presented to the emergency
department with right-sided testicular pain that began while
sitting in class. His pain had a waxing and waning quality and
further questioning revealed that it had actually began more
subtly 3 e 6 months prior. He could not identify any reason for
the acute worsening. He was taking minocycline 50 mg twice
daily for acne during this period. Review of systems was also
positive for nausea. Additional history was non-contributory. His
initial exam in the emergency department was notable for right-
sided testicular tenderness and right hemi-scrotal swelling. His
urinalysis was normal. A scrotal ultrasound showed no frank
testicular torsion or epididymitis. On repeat genitourinary exam
later that day his pain had markedly improved (however, this was
after pain medication was administered). Because of the nature of
his symptoms, intermittent testicular torsion was suspected and
the patient underwent a bilateral transscrotal orchiopexy. Intra-
operatively both testicles appeared normal with no signs of tor-
sion or previous pathology. One year after this presentation the
patient returned to his urologist with right-sided testicular pain
of the same quality to his original complaint. His history at the
time was notable only for having started taking minocycline again
2 e 3 weeks prior, which he had stopped in the interim following
his original surgery. His repeat examination was normal. Because
of the suggestive timeline, it was recommended for him to stop
taking this medication. The patient’s testicular pain resolved
within 1 week.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A 23 year-old Caucasian man presented to an outpatient urology
clinic with bilateral testicular pain. He had started taking minocy-
cline 100 mg daily 3 weeks prior to this presentation. Additional
medical, surgical, and sexual histories were non-contributory and
minocycline was his sole medication. His overall exam was normal
as was his urinalysis. A scrotal ultrasound showed no evidence of
testicular torsion or epididymitis. Due to the suggestive timeline, a
trial discontinuation of minocycline was attempted. Additionally,
because of the severity of his pain, the patient began taking
ibuprofen for symptomatic relief. At 1-month follow-up after
stopping minocycline, the patient’s pain had almost completely
subsided and he no longer required pain medication.
Discussion
Both patients experienced the onset of symptoms after at least
several weeks of minocycline use and amelioration of their symp-
toms only with discontinuation of minocycline. For helping to
identify possible adverse drug effects, Naranjo et al. suggested a
qualifying scoring system.11 Based on this scoring system, the pa-
tient in Case 1 had a score of 7 out of 13, or a “probable” adverse
drug reaction to minocycline. Similarly, the patient in Case 2 (while
he did not experience a “re-challenge” of minocycline) had a
“probable” adverse drug reaction as well with a score of 5 out of 13.
Previous reports of testicular pain with minocycline have been
in the setting of minocycline-associated vasculitides. Kermani et al.
reported four male patients with minocycline-associated vasculitis,
three of whom reported testicular or epididymal pain as part of
their symptoms.7 Testicular pain with testicular infarction has been
reported to occur in cases of minocycline-associated vasculitides as
well. Lenert et al. reported a patient with a minocycline-associated
“polyarteritis nodosa-like” syndrome who presented with testic-
ular pain and was found to have a testicular infarction prompting
orchiectomy.8 Lyon et al. also reported a case of minocycline-
associated vasculitis in which the patient developed testicular
pain and was found to have a wedge infarction of the right testicle.9
All cases were treated successfully with minocycline discontinua-
tion, in addition to immunosuppression in a select few.
All of the patients found on literature review were documented
to have met clinical or pathologic criteria for polyarteritis nodosa, a
medium-vessel necrotizing vasculitis. All of the patients in the
literature review also had abnormally elevated perinuclear anti-
neutrophil cytoplasmic antibody (pANCA) titers. While pANCA
positivity is not classically associated with polyarteritis nodosa, it
has been documented in drug-induced vasculitides before.10
Additionally, it has been suggested that exposure to minocycline
alone can induce pANCA positivity, even without the onset of
vasculitis symptoms. Marzo-Ortega et al. studied patients taking
minocycline for acne and found such individuals with abnormallyelevated pANCA titers and no history of vasculitis. While most of
these patients with pANCA positivity reported some type of mild-
to-moderate symptoms (usually arthritis), there were several who
were completely asymptomatic.12
Conclusion
Two cases are presented where testicular pain was associated
with minocycline use. The circumstances of each case suggest that
these were probably adverse drug reactions to minocycline. The
cornerstone of management for these patients, in addition to those
found literature review, was minocycline discontinuation. For pa-
tients taking minocycline who present with otherwise unexplained
or poorly-explained testicular pain, stoppingminocycline should be
considered. It is not known what laboratory tests would be helpful
or conﬁrmatory in these cases. An elevated pANCA titer has been
suggested as maker for increased risk to developing side effects
from minocycline, however this has only been demonstrated in
those with previous minocycline exposure on the order of months
to years. More study is necessary to fully describe this potential
adverse drug reaction and its pathophysiology.
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